:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
¡¡
¡¡
   
  CPMDRC °³¼Ò½Ä ¹× ¼¼¹Ì³ª
  ±Û¾´ÀÌ : ÃÖ°í°ü¸®ÀÚ     ³¯Â¥ : 08-02-21 11:09     Á¶È¸ : 1312    
ÀÏ ½Ã : 2008. 01. 23. 10½Ã~16½Ã
Àå ¼Ò : °æÈñ´ëÇб³ Ä¡°úº´¿ø 6Ãþ ¼¼¹Ì³ª½Ç

[ÀÏ Á¤]
Session ¥°°³È¸½Ä
10:30 tapeing cutting....... ³»¿Ü±Íºó
10:40 °³È¸»ç................... ¼¾ÅÍÀå
10:50 Ãà »ç .................... ³»¿Üºó
11:10 ¼¾ÅͼҰ³ ............... ¼¾ÅÍÀå
11:30 ¼¾ÅÍ tour

12:00 ¿ÀÂù

Session¥± ¼¼¹Ì³ª
14:00 ±è±Ô¿ø±³¼ö(¼­¿ï´ëÇб³, Ç÷°ü½Å°æÅëÇÕÁ¶ÀýâÀÇ¿¬±¸´ÜÀå)
        Regulation of Tumor Angiogenesis via HIF-1¥á Stability
15:00 ÁÖÀϷα³¼ö(¾ÆÁÖ´ëÇб³, ¸¸¼º¿°ÁõÁúȯ¿¬±¸¼¾ÅÍÀå)
          A Novel anti-inflammatory mechanism of PPAR agonists

   

:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::